TOKYO, Feb. 5, 2024 /PRNewswire/ — NX Global Ocean Network Pte. Ltd. (hereinafter abbreviated as "NXGO"), a group company of NIPPON EXPRESS HOLDINGS, INC., started NVOCC (*) services in Singapore on Monday, January 1, 2024.

*NVOCC (Non-Vessel Operating Common Carrier):A carrier that does not have its own means of transport such as ships or aircraft, but that takes on the responsibility of utilizing such means to transport cargo for unspecified shippers

Logo: https://kyodonewsprwire.jp/img/202401316022-O2-vih4m8uO 

Image:https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202401316022/_prw_PI1fl_12VtBuYX.png 

NXGO began operations in Singapore in May 2022 to further strengthen the Nippon Express (hereinafter "NX") Group’s international ocean freight forwarding business, and it has now launched new NVOCC services to achieve competitive prices through centralized purchasing that takes advantage of economies of scale of the entire NX Group’s international ocean freight. The NX Group will develop its services globally under the unified brand name of "NX."

The NX Group will continue expanding its international ocean freight business centered on NXGO and providing high-quality services to its customers.

Profile of NXGO- Company name: NX Global Ocean Network Pte. Ltd. (abbreviation: NXGO)- Location: 5C Toh Guan Road East, Singapore 608828- URL: https://www.nipponexpress.com/nxgo/ 

Nippon Express website: https://www.nipponexpress.com/ 

Nippon Express Group’s official LinkedIn account:https://www.linkedin.com/company/nippon-express-group/ 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Huawei Cloud Launches Palworld-dedicated Servers with One-minute Setup

SHENZHEN, China, Feb. 5, 2024 /PRNewswire/ — Palworld, a multiplayer open-world survival…

NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer

SAN FRANCISCO and SUZHOU, China, Feb. 24, 2025 /PRNewswire/ — Innovent Biologics, Inc.…

bauma CHINA 2024: XCMG Leads Industry Development with Intelligent, Digital, and Green Solutions and Products

SHANGHAI, Nov. 28, 2024 /PRNewswire/ — Leading construction machinery manufacturer XCMG Machinery ("XCMG",…